NVO Cash from Investing Activities - Cash Flow Statement - Novo Nordisk A/S - IntrinsicAlpha

Novo Nordisk A/S NVO

Healthcare - Biotechnology - NYSE - DK

$ 85.25

-0.105 %

$ 372 B

Market Cap

28.8

P/E

NVO - CASH FROM INVESTING ACTIVITIES

Cash from Investing Activities NVO - Novo Nordisk A/S

-43.9 B

LAST VALUE

-17.85%

2 YEAR CAGR

-29.44%

5 YEAR CAGR

-31.81%

10 YEAR CAGR